InMode aesthetic treatments - Face, body & skin
Patient treatment solutions with InMode technology. Comprehensive aesthetic procedures for face, body, hair removal & wellness.
inmodemd.comCrawled Nov 7, 2026
Patient treatment solutions with InMode technology. Comprehensive aesthetic procedures for face, body, hair removal & wellness.
InMode treatment gallery with real patient results. Advanced radiofrequency technology transformations for aesthetic procedures.
InMode workstation platforms for aesthetic treatments. Minimally invasive RF solutions for face, body, skin, circulatory & women's wellness.
Lumecca is promoted as a skin rejuvenation treatment.
Diode lasers are often used for hair removal due to their deep penetration and effective targeting of hair follicles. They vary in parameters such as fluence, pulse duration, repetition rate, scanner, and cooling.
Dr. Daria Hamrah discusses AccuTite, FaceTite, and Morpheus8, with special considerations for patients of color.
Author: Mark H. Peters, MD Publication: Plastic and Reconstructive Surgery Published Date: October 2022
InMode develops and markets radio-frequency-based medical technologies for minimally invasive and surgical procedures.
Dr. Dlivro Beauchamp is board certified in Urgent Care Medicine, and specializes in aesthetics and anti-aging medicine. Dr. Beauchamp is a leader in the medical community, and is active in providing urgent care medical services to the Montgomery community.
As one of the Plano area’s most prominent resources for quality healthcare, First Choice Physical Medicine specializes in a wide range of medical services to get patients feeling healthier than ever before.
Dr. James Spencer is recognized internationally for his research in cosmetic surgery and skin cancer treatment. As an educator to other physicians, he is a frequent guest speaker at national and international medical conferences regarding cosmetic and laser surgery.
Address: 520 Medical Dr, Ste 320 Bountiful, UT 84010 United States
Integrative Dermatology offers personalized treatment plans led by Dr. Laura E. Skellchock, a board-certified dermatologist with experience in cosmetic and general dermatology.
Dr. Stephen J Beck is a board certified dermatologist, and specializes in skin cancer surgery. Dr. Beck has over 20 years of dermatological experience, and has received many continuing education awards by medical societies in America.
About InMode - Leading aesthetic medical device innovator. Advanced radiofrequency technology and minimally invasive solutions.
InMode provides advanced aesthetic medical devices using radiofrequency technology for facial, body, and wellness treatments.
Steel Partners Holdings L.P. releases an open letter to all InMode stakeholders, reaffirming its $16.75 per share all-cash takeover offer. The company sets an expiration date of **October 30, 2026**, for its proposal after over three months without engagement from InMode. Steel Partners continues to press for a response regarding its acquisition bid.
InMode projects third-quarter 2026 revenue between **$91.8 million and $92.0 million**. The company, a provider of medical technologies, also reaffirms its full-year 2026 revenue guidance of **$365 million to $375 million**. Results will be announced on **November 11, 2026**, before Nasdaq market open.
M.N. Business Strategy offers to acquire all outstanding shares of InMode Ltd. for $16.20 per share in cash. The proposal, received on June 17, 2026, targets shares not already owned by MN Business Strategy or its affiliates. InMode’s board is reviewing the unsolicited bid.
InMode authorizes a new share repurchase program covering up to **6.38 million ordinary shares**, or roughly **10% of its outstanding shares**. The company, a provider of medical technologies, seeks to buy back shares under the newly approved plan. The move reflects strategic capital allocation by the Board of Directors.
InMode reports **$93.2 million in revenue** for Q3 2025, achieving **78% gross margins** in its latest quarterly results. The company, specializing in medical technologies, highlights continued financial performance in its third-quarter earnings announcement. Key metrics include strong profitability and revenue growth, reflecting its position in the global medical tech market.